On 4 June, The New York Times posted an online story with a dramatic headline: “In a First, Scientists Precisely Edit Human Embryo Genes.” Others quickly echoed the claim, reigniting a simmering debate over whether it’s safe, ethical, and worthwhile to create gene-edited babies. But the reality of the reported advance, an effort to improve the use in embryos of an approach called base editing, is more subtle than many stories suggested. (The New York Times changed its online headline by the next day to eliminate the “first” claim.)
Even the stem cell scientist who led the new work acknowledges the tool still has major limitations and says it shouldn’t yet be used to make a baby. “I think it [our findings] will shift the conversation but it won’t change the landscape of use anytime soon,” he says.
Science delves behind the headlines to look closer at his group’s research, posted as a preprint on 1 June:
scim.ag/4urOwGR
ALT An embryo editing ‘first’ is more complicated than headlines suggest
Scientists may have a better way to make gene-edited babies, but it’s still far from safe